Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125623672 | 12562367 | 2 | F | 20151130 | 20160804 | 20160715 | 20160817 | EXP | IT-CELGENEUS-ITA-2015121048 | CELGENE | 41.00 | YR | F | Y | 0.00000 | 20160817 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125623672 | 12562367 | 1 | PS | ROMIDEPSIN | ROMIDEPSIN | 1 | Intravenous drip | 14MG/M2 | U | 63573 | 21.42 | MG/M**2 | INJECTION FOR INFUSION | QD | |||||
| 125623672 | 12562367 | 2 | SS | ROMIDEPSIN | ROMIDEPSIN | 1 | Intravenous drip | U | 63573 | 14 | MG/M**2 | INJECTION FOR INFUSION | QD | ||||||
| 125623672 | 12562367 | 3 | SS | ROMIDEPSIN | ROMIDEPSIN | 1 | Intravenous drip | U | 63573 | 14 | MG/M**2 | INJECTION FOR INFUSION | QD | ||||||
| 125623672 | 12562367 | 4 | SS | ROMIDEPSIN | ROMIDEPSIN | 1 | Intravenous drip | U | 63573 | 14 | MG/M**2 | INJECTION FOR INFUSION | QD | ||||||
| 125623672 | 12562367 | 5 | SS | ROMIDEPSIN | ROMIDEPSIN | 1 | Intravenous drip | U | 63573 | 14 | MG/M**2 | INJECTION FOR INFUSION | QD | ||||||
| 125623672 | 12562367 | 6 | SS | ROMIDEPSIN | ROMIDEPSIN | 1 | Intravenous drip | U | 63573 | 14 | MG/M**2 | INJECTION FOR INFUSION | QD | ||||||
| 125623672 | 12562367 | 7 | SS | Doxorubicin | DOXORUBICIN | 1 | Unknown | U | U | 0 | 73.5 | MG | UNKNOWN | ||||||
| 125623672 | 12562367 | 8 | SS | Doxorubicin | DOXORUBICIN | 1 | Unknown | U | U | 0 | 73.5 | MG | UNKNOWN | ||||||
| 125623672 | 12562367 | 9 | SS | Vincristine | VINCRISTINE | 1 | Unknown | U | U | 0 | 2 | MG | UNKNOWN | ||||||
| 125623672 | 12562367 | 10 | SS | Vincristine | VINCRISTINE | 1 | Unknown | U | U | 0 | 2 | MG | UNKNOWN | ||||||
| 125623672 | 12562367 | 11 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | U | U | 0 | 1102.5 | MG | UNKNOWN | ||||||
| 125623672 | 12562367 | 12 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | U | U | 0 | 1102.5 | MG | UNKNOWN | ||||||
| 125623672 | 12562367 | 13 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | U | U | 0 | 147 | MG | UNKNOWN | ||||||
| 125623672 | 12562367 | 14 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | U | U | 0 | 147 | MG | UNKNOWN | ||||||
| 125623672 | 12562367 | 15 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Unknown | U | U | 0 | UNKNOWN | ||||||||
| 125623672 | 12562367 | 16 | C | TRIMETHOPRIM. | TRIMETHOPRIM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125623672 | 12562367 | 17 | C | Sulfamethoxazole | SULFAMETHOXAZOLE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125623672 | 12562367 | 18 | C | VALGANCICLOVIR. | VALGANCICLOVIR | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125623672 | 12562367 | 19 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125623672 | 12562367 | 20 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125623672 | 12562367 | 21 | C | CEFIXIME. | CEFIXIME | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125623672 | 12562367 | 22 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125623672 | 12562367 | 23 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125623672 | 12562367 | 1 | T-cell lymphoma |
| 125623672 | 12562367 | 7 | T-cell lymphoma |
| 125623672 | 12562367 | 9 | T-cell lymphoma |
| 125623672 | 12562367 | 11 | T-cell lymphoma |
| 125623672 | 12562367 | 13 | T-cell lymphoma |
| 125623672 | 12562367 | 15 | T-cell lymphoma |
| 125623672 | 12562367 | 16 | Product used for unknown indication |
| 125623672 | 12562367 | 17 | Product used for unknown indication |
| 125623672 | 12562367 | 18 | Product used for unknown indication |
| 125623672 | 12562367 | 19 | Product used for unknown indication |
| 125623672 | 12562367 | 20 | Product used for unknown indication |
| 125623672 | 12562367 | 21 | Product used for unknown indication |
| 125623672 | 12562367 | 22 | Product used for unknown indication |
| 125623672 | 12562367 | 23 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125623672 | 12562367 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125623672 | 12562367 | Chills | |
| 125623672 | 12562367 | Febrile neutropenia | |
| 125623672 | 12562367 | Oxygen saturation decreased | |
| 125623672 | 12562367 | Pyrexia | |
| 125623672 | 12562367 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125623672 | 12562367 | 1 | 20151130 | 20151207 | 0 | |
| 125623672 | 12562367 | 2 | 20151222 | 20151229 | 0 | |
| 125623672 | 12562367 | 3 | 20160112 | 20160119 | 0 | |
| 125623672 | 12562367 | 4 | 20160202 | 20160209 | 0 | |
| 125623672 | 12562367 | 5 | 20160223 | 20160301 | 0 | |
| 125623672 | 12562367 | 6 | 20160315 | 20160322 | 0 | |
| 125623672 | 12562367 | 8 | 20151222 | 0 | ||
| 125623672 | 12562367 | 10 | 20151222 | 0 | ||
| 125623672 | 12562367 | 12 | 20151222 | 0 | ||
| 125623672 | 12562367 | 14 | 20151222 | 0 | ||
| 125623672 | 12562367 | 18 | 20151201 | 0 |